Related Experiment Videos

Erythromycin increases gastric antral motility in human premature infants

T Tomomasa1, M Miyazaki, T Koizumi

  • 1Department of Pediatrics, Gunma University School of Medicine, Japan.

Biology of the Neonate
|January 1, 1993
PubMed

Insights

Erythromycin (EM) stimulates gastrointestinal contractions in premature infants, indicating functioning motilin receptors. This study investigated EM

Area of Science:

  • Neonatal Physiology
  • Gastrointestinal Motility Research
  • Pharmacology

Background:

  • Premature infants often experience gastrointestinal dysmotility.
  • Erythromycin (EM) is a known motilin agonist.
  • The effect of EM on neonatal GI motility requires further investigation.

Purpose of the Study:

  • To determine if erythromycin (EM) alters gastrointestinal motility in premature infants.
  • To assess the presence and function of motilin receptors in preterm neonates.

Main Methods:

  • Studied six infants born between 23-30 weeks gestation.
  • Recorded intraluminal pressure in the gastric antrum and proximal duodenum.
  • Administered intravenous EM (0.75 mg/kg) and compared motility before and after infusion.

Main Results:

  • Erythromycin (EM) increased nonpropagating antral contractions in all infants.
  • The antral motility index showed a 4-fold increase after EM administration.
  • Migrating complexes were absent and not induced by EM in this cohort.

Conclusions:

  • Premature infants possess functional motilin receptors.
  • Erythromycin (EM) stimulates antral motility in preterm neonates.
  • Findings suggest potential therapeutic applications for EM in neonatal GI disorders.

Related Concept Videos